For example, OR2W3 upregulation is associated with decreased survival probability [82], and OR51J1 is overexpressed in HER2-enriched and triple-negative tumors compared to luminal BC but does not correlate with tumor morphologic characteristics [77]. The gene discussed is ERBB2; the disease is breast cancer.